Large granular lymphocyte leukemia

Oncologist

Volumn 11, Issue 3, 2006, Pages 263-273

  Sokol, Lubomir ^a   Loughran Jr , Thomas P ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Aggressive NK cell leukemia; Autoimmunity; Cytopenia; T cell LGL leukemia

Indexed keywords

2 CHLOROXYADENOSINE; ADENOSINE; ALEMTUZUMAB; CD3 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; FLUDARABINE; METHOTREXATE; PENTOSTATIN; PREDNISONE; SIPLIZUMAB; THYMOCYTE ANTIBODY; TIPIFARNIB; UNCLASSIFIED DRUG; VINCRISTINE;

ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CARCINOGENESIS; CELL MATURATION; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; CLONAL VARIATION; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFICACY; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LARGE GRANULAR LYMPHOCYTE; LOW DRUG DOSE; LYMPHATIC LEUKEMIA; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR MECHANICS; NATURAL KILLER CELL; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SPLENECTOMY; T CELL LEUKEMIA; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; X CHROMOSOME INACTIVATION;

ALGORITHMS; AUTOIMMUNE DISEASES; CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC DISEASES; HUMANS; LEUKEMIA, T-CELL; PHENOTYPE;

EID: 33645056193     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.11-3-263     Document Type: Article

References (76)

1. Lamy T, Loughran TP. Large granular lymphocyte leukemia. Cancer Control 1998;5:25-33.
2. Loughran TP Jr, Kadin ME, Starkebaum G et al. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 1985;102:169-175.
3. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
4. Dhodapkar MV, Li CY, Lust JA et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994;84:1620-1627.
5. Semenzato G, Pandolfi F, Chisesi T et al. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987;60:2971-2978.
6. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999;10:1419-1432.
7. + aggressive variant of large granular lymphocyte leukemia. Blood 1994;84:2315-2321.
8. Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia. Semin Hematol 2003;40:185-195.
9. + T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood 1994;83:587-595.
10. Halwani F, Guttmann RD, Ste-Croix H et al. Identification of natural suppressor cells in long-term renal allograft recipients. Transplantation 1992;54:973-977.
11. Sampalo Lainz A, Lopez-Gomez M, Jimenez-Alonso J. [Proliferation of large granular lymphocytes in patients with systemic lupus erythematosus]. Rev Clin Esp 1995;195:373-379. Spanish.
12. + T cell clones in elderly humans. J Immunol 1997;158:4493-4499.
13. + lymphocytes in HIV infection. J Clin Pathol 2000;53:177-181.
14. Fernandez LA, Pope B, Lee C et al. Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line. Blood 1986;67:925-930.
15. Suzuki R, Suzumiya J, Nakamura S et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004;18:763-770.
16. Ruskova A, Thula R, Chan G. Aggressive natural killer-cell leukemia: report of five cases and review of the literature. Leuk Lymphoma 2004;45:2427-2438.
17. Epling-Burnette PK, Loughran TP Jr. Survival signals in leukemic large granular lymphocytes. Semin Hematol 2003;40:213-220.
18. + granular lymphocytes. Cancer Res 1995;55:6140-6145.
19. O'Keefe CL, Plasilova M, Wlodarski M et al. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J Immunol 2004;172:1960-1969.
20. Wlodarski MW, O'Keefe C, Howe EC et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 2005;106:2769-2780.
21. Loughran TP Jr, Coyle T, Sherman MP et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 1992;80:1116-1119.
22. Loughran TP Jr, Hadlock KG, Perzova R et al. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 1998;101:318-324.
23. - (natural killer) lymphoproliferative disease of granular lymphocytes. Blood 1997;90:1977-1981.
24. Sokol L, Agrawal D, Loughran TP Jr. Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia. Leuk Res 2005;29:381-387.
25. Pawson R, Schulz TF, Matutes E et al. The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia. Leukemia 1997;11:1305-1311.
26. Perzova RN, Loughran TP, Dube S et al. Lack of BLV and PTLV DNA sequences in the majority of patients with large granular lymphocyte leukaemia. Br J Haematol 2000;109:64-70.
27. Hart DN, Baker BW, Inglis MJ et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992;79:2116-2123.
28. + T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis. Leuk Res 2001;25:699-708.
29. Horiuchi T, Hirokawa M, Satoh K et al. Clonal expansion of gammadelta-T lymphocytes in an HTLV-I carrier, associated with chronic neutropenia and rheumatoid arthritis. Ann Hematol 1999;78:101-104.
30. + hematologic mal ignancies. Leuk Res 1999;23:675-676.
31. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005;19:2186-2194.
32. Tefferi A, Li CY, Witzig TE et al. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994;84:2721-2725.
33. Oshimi K, Yamada O, Kaneko T et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993;7:782-788.
34. Wong KF, Chan JC, Liu HS et al. Chromosomal abnormalities in T-cell large granular lymphocyte leukaemia: report of two cases and review of the literature. Br J Haematol 2002;116:598-600.
35. Hamaguchi H, Yamaguchi M, Nagata K et al. Aggressive NK cell lymphoma/leukemia with clonal der(3)t(1;3) (q12;p25), del(6)(q13) and del(13)(q12q14). Cancer Genet Cytogenet 2001;130:150-154.
36. Wong KF, Zhang YM, Chan JK. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia - is there a consistent pattern? Leuk Lymphoma 1999;34:241-250.
37. Ryan DK, Alexander HD, Morris TC. Routine diagnosis of large granular lymphocytic leukaemia by Southern blot and polymerase chain reaction analysis of clonal T cell receptor gene rearrangement. Mol Pathol 1997;50:77-81.
38. van den Beemd R, Boor PP, van Lochem EG et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000;40:336-345.
39. Zambello R, Semenzato G. Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes. Semin Hematol 2003;40:201-212.
40. Epling-Burnette PK, Painter JS, Chaurasia P et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 2004;103:3431-3439.
41. Osuji N, Matutes E, Catovsky D et al. Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review. Am J Surg Pathol 2005;29:935-941.
42. Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 1999;106:960-966.
43. Semenzato G, Zambello R, Starkebaum G et al. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997;89:256-260.
44. Evans HL, Burks E, Viswanatha D et al. Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia. Hum Pathol 2000;31:1266-1273.
45. Gonzales-Chambers R, Przepiorka D, Winkelstein A et al. Lymphocyte subsets associated with T cell receptor beta-chain gene rearrangement in patients with rheumatoid arthritis and neutropenia. Arthritis Rheum 1992;35:516-520.
46. Morice WG, Kurtin PJ, Tefferi A et al. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 2002;99:268-274.
47. Perzova R, Loughran TP Jr. Constitutive expression of Fas ligand in large granular lymphocyte leukaemia. Br J Haematol 1997;97:123-126.
48. Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology (Am Soc Hematol Educ Program) 2004:63-79.
49. Loughran TP Jr, Clark EA, Price TH et al. Adult-onset cyclic neutropenia is associated with increased large granular lymphocytes. Blood 1986;68:1082-1087.
50. + large granular lymphocyte leukemia. Leuk Lymphoma 1996;23:405-408.
51. Go RS, Li CY, Tefferi A et al. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 2001;98:483-485.
52. Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol 2000;111:1010-1022.
53. Nadeau L, Meyerson H, Warren G et al. A sustained response to low dose interferon-alpha in a case of refractory pure red cell aplasia. Eur J Haematol 2004;73:300-303.
54. Bassan R, Pronesti M, Buzzetti M et al. Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells. Cancer 1989;63:90-95.
55. Starkebaum G, Loughran TP Jr, Gaur LK et al. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997;40:624-626.
56. Bowman SJ, Sivakumaran M, Snowden N et al. The large granular lymphocyte syndrome with rheumatoid arthritis. Immunogenetic evidence for a broader definition of Felty's syndrome. Arthritis Rheum 1994;37:1326-1330.
57. Molad Y, Okon E, Stark P et al. Sjogren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis. J Rheumatol 2001;28:2551-2552.
58. Pandolfi F, Loughran TP Jr, Starkebaum G et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer 1990;65:341-348.
59. Battiwalla M, Melenhorst J, Saunthararajah Y et al. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. Br J Haematol 2003;123:449-453.
60. Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994;84:2164-2170.
61. Matrai Z, Lelkes G, Milosevits J et al. [T-cell large granular lymphocytic leukemia associated with pure red cell aplasia, successfully treated with cyclophosphamide]. Orv Hetil 1997;138:2075-2080. Hungarian.
62. Liu JH, Wei S, Lamy T et al. Chronic neutropenia mediated by fas ligand. Blood 2000;95:3219-3222.
63. Mercieca J, Matutes E, Dearden C et al. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol 1994;12:2588-2593.
64. Osuji N, Del Giudice I, Matutes E et al. CD52 expression in T-cell large granular lymphocyte leukemia - implications for treatment with alemtuzumab. Leuk Lymphoma 2005;46:723-727.
65. Rossoff LJ, Genovese J, Coleman M et al. Primary pulmonary hypertension in a patient with CD8/T-cell large granulocyte leukemia: amelioration by cladribine therapy. Chest 1997;112:551-553.
66. Sternberg A, Eagleton H, Pillai N et al. Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity. Br J Haematol 2003;120:699-701.
67. Lamy T, LePrise PY, Amiot L et al. Response to granulocyte-macrophage colony-stimulating factor (GM-CSF) but not to G-CSF in a case of agranulocytosis associated with large granular lymphocyte (LGL) leukemia. Blood 1995;85:3352-3353.
68. Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol 2002;39:121-127.
69. Weide R, Heymanns J, Koppler H et al. Successful treatment of neutropenia in T-LGL leukemia (T gamma-lymphocytosis) with granulocyte colony-stimulating factor. Ann Hematol 1994;69:117-119.
70. Bargetzi MJ, Wortelboer M, Pabst T et al. Severe neutropenia in T-large granular lymphocyte leukemia corrected by intensive immunosuppression. Ann Hematol 1996;73:149-151.
71. Kwong YL, Wong KF. Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Clin Pathol 1998;51:672-675.
72. Loughran TP Jr, Starkebaum G, Clark E et al. Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol 1987;67:135-140.
73. Epling-Burnette PK, Bai F, Wei S et al. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 2004;23:9220-9229.
74. Toze CL, Shepherd JD, Connors JM et al. Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia. Bone Marrow Transplant 2000;25:605-612.
75. Ebihara Y, Manabe A, Tanaka R et al. Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation. Bone Marrow Transplant 2003;31:1169-1171.
76. Okamura T, Kishimoto T, Inoue M et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant 2003;31:105-111.